REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 6 filers reported holding REGENERON PHARMACEUTICALS in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $98,273,000 | +30.6% | 281,400 | +34.8% | 0.11% | +15.8% |
| Q1 2016 | $75,224,000 | -29.5% | 208,700 | +6.2% | 0.10% | -18.1% |
| Q4 2015 | $106,728,000 | -7.4% | 196,600 | -20.7% | 0.12% | +6.4% |
| Q3 2015 | $115,262,000 | +27.9% | 247,800 | +40.3% | 0.11% | +39.7% |
| Q2 2015 | $90,089,000 | +14.4% | 176,600 | +1.3% | 0.08% | +4.0% |
| Q1 2015 | $78,738,000 | -1.9% | 174,400 | -10.9% | 0.08% | -5.1% |
| Q4 2014 | $80,286,000 | +52.9% | 195,700 | +34.4% | 0.08% | +43.6% |
| Q3 2014 | $52,492,000 | +41.4% | 145,600 | +10.8% | 0.06% | +27.9% |
| Q2 2014 | $37,117,000 | -4.3% | 131,400 | +1.7% | 0.04% | -4.4% |
| Q1 2014 | $38,796,000 | -18.1% | 129,200 | -25.0% | 0.04% | -27.4% |
| Q4 2013 | $47,396,000 | -22.5% | 172,200 | -11.9% | 0.06% | -33.3% |
| Q3 2013 | $61,135,000 | +93.5% | 195,400 | +39.1% | 0.09% | +72.2% |
| Q2 2013 | $31,596,000 | – | 140,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMC-Chicago, LLC | 73,100 | $35,315,000 | 0.04% |
| GROUP ONE TRADING, L.P. | 46,700 | $22,561,000 | 0.04% |
| SIMPLEX TRADING, LLC | 365 | $17,633,000 | 0.02% |
| SG Americas Securities, LLC | 19,200 | $2,212,000 | 0.01% |
| JPMORGAN CHASE & CO | 22,500 | $10,870,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |